Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.
D000818:Animals; D000937:Antigen-Antibody Reactions; D000941:Antigens; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D003315:Cornea / Q000276:immunology / Q000601:surgery; D003318:Corneal Opacity / Q000276:immunology; D016039:Corneal Transplantation; D062109:Dermatologic Surgical Procedures; D004487:Edema; D007106:Immune Sera / Q000008:administration & dosage*; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008214:Lymphocytes; D011817:Rabbits; D016038:Skin Transplantation; D014181:Transplantation Immunology / Q000187:drug effects*; D014184:Transplantation, Homologous; D014652:Vascular Diseases / Q000276:immunology
D000941:Antigens; D000961:Antilymphocyte Serum; D007106:Immune Sera; D007166:Immunosuppressive Agents